Lv1
20 积分 2024-01-09 加入
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
1天前
已完结
Novel insights into molecular and immune subtypes of biliary tract cancers
2天前
已完结
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
8天前
已完结
Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study
14天前
已完结
Case 17-2024: A 45-Year-Old Woman with Metastatic Breast Cancer
16天前
已完结
Antibody-drug conjugates in metastatic breast cancer: sequencing, combinations and resistances
19天前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
20天前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
20天前
已完结
Osimertinib combined with anlotinib as first-line treatment in advanced or metastatic NSCLC patients with EGFR mutation: a prospective, single arm, exploratory study
21天前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
23天前
已完结
皖公网安备34019202002308
